Cecal Appendix Neuroendocrine Tumors: the Experience of the Brazilian National Cancer Institute

Authors

  • Rodrigo Lopes da Silva Hospital Erasto Gaertner. Curitiba (PR), Brasil. Instituto Nacional do Câncer (INCA). Rio de Janeiro (RJ), Brasil.
  • Eduardo Linhares Universidade Federal do Rio de Janeiro (UFRJ). RJ, Brasil. Instituto Nacional do Câncer (INCA). Rio de Janeiro (RJ), Brasil.
  • Rinaldo Gonçalves Universidade Federal do Rio de Janeiro (UFRJ). Rio de Janeiro (RJ), Brasil. Instituto Nacional do Câncer (INCA). Rio de Janeiro (RJ), Brasil.
  • Cintia Ramos Instituto Nacional do Câncer (INCA), Rio de Janeiro (RJ), Brasil.

DOI:

https://doi.org/10.32635/2176-9745.RBC.2010v56n4.696

Keywords:

Appendix, Neuroendocrine Tumors, Carcinoid Tumor

Abstract

Introduction: The cecal appendix is the second most common site for neuroendocrine tumors in all of the digestive tract, with a relative rate of 25-30%. They are usually diagnosed incidentally during appendectomies or other abdominal surgeries. Objectives: To analyze a series of cases of appendix neuroendocrine tumors treated at the Abdominal-pelvic Surgery Service of the Brazilian National Cancer Institute and describe the approach used in this Service for the treatment of this group of neoplasms. Material and Methods: Report of a series of 13 cases, through the retrospective analysis of the medical records of patients with appendix neuroendocrine tumors treated at the Abdominal-pelvic Surgery Service of the Brazilian National Cancer Institute from 1996 to 2008. Results: The average age at diagnosis was 44.7, with a predominance of women over men in a ratio of 5.5:1. Tumor size ranged from 0.3 to 6 cm, with a median of 2.3 cm. After an average follow up of 32 months, 10 (77%) patients were alive, one (7.7%) missed the follow-up and two (15.3%) died. Conclusion: Appendix neuroendocrine tumors are relatively rare and have good prognosis. The simple appendectomy is the routine surgical treatment and provides cure in most cases. The criteria proposed by the European Neuroendocrine Tumor Society for the treatment of these tumors are easily reproducible and are currently being used as routine in this Service.

 

Downloads

Download data is not yet available.

Published

2010-12-31

How to Cite

1.
Silva RL da, Linhares E, Gonçalves R, Ramos C. Cecal Appendix Neuroendocrine Tumors: the Experience of the Brazilian National Cancer Institute. Rev. Bras. Cancerol. [Internet]. 2010 Dec. 31 [cited 2024 May 11];56(4):463-70. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/696

Issue

Section

ORIGINAL ARTICLE